Press releases
- Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference
- Bio-Rad Reports First-Quarter 2024 Financial Results
- Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
- Bio-Rad Announces Life Science Group Management Changes
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
- Bio-Rad’s Chief Operating Officer Andrew Last to Retire
- Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
More ▼
Key statistics
As of last trade Bio Rad Laboratories Inc (BUWA:DUS) traded at 266.30, 8.34% above its 52-week low of 245.80, set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 266.40 |
---|---|
High | 266.40 |
Low | 266.30 |
Bid | 266.30 |
Offer | 270.60 |
Previous close | 268.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 28.52m |
Free float | 19.98m |
P/E (TTM) | -- |
Market cap | 8.23bn USD |
EPS (TTM) | -10.36 USD |
Data delayed at least 15 minutes, as of May 24 2024 08:30 BST.
More ▼